North Crest Asset Manangement, LLC Biogen Inc. Transaction History
North Crest Asset Manangement, LLC
- $2.92 Billion
- Q2 2024
A detailed history of North Crest Asset Manangement, LLC transactions in Biogen Inc. stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 31,472 shares of BIIB stock, worth $5.84 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
31,472
Previous 31,434
0.12%
Holding current value
$5.84 Million
Previous $6.78 Million
7.63%
% of portfolio
0.25%
Previous 0.24%
Shares
11 transactions
Others Institutions Holding BIIB
# of Institutions
1,049Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.08 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.03 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.7 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.32 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.05 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $26.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...